US Stock MarketDetailed Quotes

GDRX GoodRx

Watchlist

5.040
+0.010+0.20%

Close Feb 14 16:00 ET

5.040
0.0000.00%

Post 20:01 ET

1.92BMarket Cap-126.00P/E (TTM)

GoodRx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GoodRx Q4 2024 Estimates Date

Currency：USDFeb 27, 2025

	Estimate	YoY
Revenue	199.73M	+1.57%
EPS	0.03	+156.09%

Analyst Rating

Buy

Feb 15, 2025

GoodRx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 202.575M	--
Feb 27, 2025	2024/Q4	-- / 199.733M	--
Nov 7, 2024	2024/Q3	195.251M / 195.655M	--
Aug 8, 2024	2024/Q2	200.610M / 200.428M	--
May 9, 2024	2024/Q1	197.880M / 196.098M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 202.575M--

Feb 27, 20252024/Q4-- / 199.733M--

Nov 7, 20242024/Q3195.251M / 195.655M--

Aug 8, 20242024/Q2200.610M / 200.428M--

May 9, 20242024/Q1197.880M / 196.098M--

Unlock Free Earnings Estimates

Open Account

GoodRx Earnings Reports

GoodRx | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 14:03 ET

GoodRx | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 13:19 ET

GoodRx | 10-Q: Q1 2024 Earnings Report

May 9, 2024 15:58 ET

GoodRx | 8-K: GOODRX REPORTS FIRST QUARTER 2024 RESULTS

May 9, 2024 06:10 ET